Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
Alemtuzumab
alemtuzumab
Brand names: Campath
| Form | Strength |
|---|---|
| SOLUTION, INTRAVENOUS | 30 mg/mL |
Last updated: Jan. 11, 2022
- Black Box Warning: Hematological toxicity; opportunistic infections
- REMS: Lemtrada Injection, Solution
- Restricted Restricted Medication
Restricted to infusion clinic administration with required REMS enrollment and prior authorization before administration.
REMS website